Recently Released Market Study: Sialix, Inc. - Product Pipeline Analysis
Sialix, Inc. (Sialix) develops products for treatment and prevention of the cancer and chronic inflammatory conditions. It products are based on the new biological discoveries of non-human sialic acids; dietary roles and inflammatory consequences; their potential impact on cardiovascular, cancer; and other inflammatory-mediated diseases. Sialix's product development program include an oncology therapeutic for solid tumors, like breast, ovarian and colon cancer; and prophylactic nutritional supplement to prevent chronic inflammatory conditions which are associated with the ingestion of a non-human sialic...
View full press release